{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:33:19Z","timestamp":1762003999699},"reference-count":48,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Cardiovascular Medicine"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1016\/j.tcm.2007.02.006","type":"journal-article","created":{"date-parts":[[2007,5,4]],"date-time":"2007-05-04T15:24:47Z","timestamp":1178292287000},"page":"129-133","source":"Crossref","is-referenced-by-count":18,"title":["\u03b1-Galactosidase A in Vascular Disease"],"prefix":"10.1016","volume":"17","author":[{"given":"Peter F.","family":"Bodary","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James A.","family":"Shayman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel T.","family":"Eitzman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tcm.2007.02.006_bib1","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1172\/JCI9711","article-title":"Reduction of globotriaosylceramide in Fabry disease mice by substrate deprivation","volume":"105","author":"Abe","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.tcm.2007.02.006_bib2","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1212\/01.WNL.0000166000.24321.4F","article-title":"Effect of genetic modifiers on cerebral lesions in Fabry disease","volume":"64","author":"Altarescu","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.tcm.2007.02.006_bib3","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1365-2133.1898.tb16317.x","article-title":"A case of \u201cangio-keratoma\u201d","volume":"10","author":"Anderson","year":"1898","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.tcm.2007.02.006_bib4","first-page":"227","article-title":"Fabry disease: twenty-two novel mutations in the alpha-galactosidase A gene and genotype\/phenotype correlations in severely and mildly affected hemizygotes and heterozygotes","volume":"48","author":"Ashton-Prolla","year":"2000","journal-title":"J Investig Med"},{"key":"10.1016\/j.tcm.2007.02.006_bib5","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/0002-9149(75)90468-3","article-title":"Cardiac manifestations of Fabry's disease. Report of a case with mitral insufficiency and electrocardiographic evidence of myocardial infarction","volume":"36","author":"Becker","year":"1975","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.tcm.2007.02.006_bib6","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1159\/000087675","article-title":"Cardiopulmonary exercise testing in Fabry disease","volume":"72","author":"Bierer","year":"2005","journal-title":"Respiration"},{"key":"10.1016\/j.tcm.2007.02.006_bib7","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1161\/01.CIR.0000154550.15963.80","article-title":"Alpha-galactosidase A deficiency accelerates atherosclerosis in mice with apolipoprotein E deficiency","volume":"111","author":"Bodary","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2007.02.006_bib8","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJM196705252762101","article-title":"Enzymatic defect in Fabry's disease. Cereamidetrihexosidase deficiency","volume":"276","author":"Brady","year":"1967","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2007.02.006_bib9","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1161\/01.ATV.18.10.1523","article-title":"Sphingolipids in atherosclerosis and vascular biology","volume":"18","author":"Chatterjee","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.tcm.2007.02.006_bib10","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.1182\/blood.V96.13.4222","article-title":"Spontaneous thrombosis in mice carrying the factor V Leiden mutation","volume":"96","author":"Cui","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.tcm.2007.02.006_bib11","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0022-2275(20)36996-0","article-title":"Distribution of glycosphingolipids in the serum lipoproteins of normal human subjects and patients with hypo- and hyperlipidemias","volume":"17","author":"Dawson","year":"1976","journal-title":"J Lipid Res"},{"key":"10.1016\/j.tcm.2007.02.006_bib12","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0021-9258(18)63406-4","article-title":"In vivo studies on glycosphingolipid metabolism in porcine blood","volume":"245","author":"Dawson","year":"1970","journal-title":"J Biol Chem"},{"key":"10.1016\/j.tcm.2007.02.006_bib13","series-title":"The metabolic and molecular bases of inherited disease","first-page":"3733","article-title":"Alpha-galactosidase A deficiency: Fabry Disease","author":"Desnick","year":"2001"},{"key":"10.1016\/j.tcm.2007.02.006_bib14","first-page":"88","article-title":"Fabry disease: correction of the enzymatic deficiency by renal transplantation","volume":"9","author":"Desnick","year":"1973","journal-title":"Birth Defects Orig Artic Ser"},{"issue":"Pt 1","key":"10.1016\/j.tcm.2007.02.006_bib15","first-page":"139","article-title":"Diagnostic electron microscopy. II. Fabry's disease: use of biopsies from uninvolved skin. Acute and chronic changes involving the microvasculature and small unmyelinated nerves","volume":"16","author":"Dvorak","year":"1981","journal-title":"Pathol Annu"},{"key":"10.1016\/j.tcm.2007.02.006_bib16","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/01.ASN.0000043901.45141.D4","article-title":"Fabry disease in mice is associated with age-dependent susceptibility to vascular thrombosis","volume":"14","author":"Eitzman","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.tcm.2007.02.006_bib17","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1161\/01.CIR.0000017361.39256.82","article-title":"Lethal perinatal thrombosis in mice resulting from the interaction of tissue factor pathway inhibitor deficiency and factor V Leiden","volume":"105","author":"Eitzman","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2007.02.006_bib18","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200107053450102","article-title":"Safety and efficacy of recombinant human \u03b1-galactosidase a replacement therapy in Fabry's disease","volume":"345","author":"Eng","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2007.02.006_bib19","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF01986897","article-title":"Ein Beitrag zur Kenntnis der Purpura haemorrhagica nodularis","volume":"111","author":"Fabry","year":"1898","journal-title":"Arch Dermatol Syph"},{"key":"10.1016\/j.tcm.2007.02.006_bib20","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0002-9149(69)90055-1","article-title":"The heart in Fabry's disease. A histochemical and electron microscopic study","volume":"24","author":"Ferrans","year":"1969","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.tcm.2007.02.006_bib21","doi-asserted-by":"crossref","first-page":"221","DOI":"10.7326\/0003-4819-117-3-221","article-title":"Fabry disease: an unusual cause of severe coronary disease in a young man","volume":"117","author":"Fisher","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.tcm.2007.02.006_bib22","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1097\/00007890-200005270-00022","article-title":"Allograft loss in renal transplant recipients with Fabry's disease and activated protein C resistance","volume":"69","author":"Friedman","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.tcm.2007.02.006_bib23","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0092-8674(01)00238-0","article-title":"Atherosclerosis: the road ahead","volume":"104","author":"Glass","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.tcm.2007.02.006_bib24","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1146\/annurev.bi.46.070177.004341","article-title":"The low-density lipoprotein pathway and its relation to atherosclerosis","volume":"46","author":"Goldstein","year":"1977","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.tcm.2007.02.006_bib25","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF00868342","article-title":"Stroke in Fabry's disease","volume":"241","author":"Grewal","year":"1994","journal-title":"J Neurol"},{"key":"10.1016\/j.tcm.2007.02.006_bib26","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/oxfordjournals.jbchem.a124992","article-title":"Functional role of glycosphingolipids in cell recognition and signaling","volume":"118","author":"Hakomori","year":"1995","journal-title":"J Biochem (Tokyo)"},{"key":"10.1016\/j.tcm.2007.02.006_bib27","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1086\/316953","article-title":"Fabry disease: preclinical studies demonstrate the effectiveness of \u03b1-galactosidase A preplacement in enzyme-deficient mice","volume":"68","author":"Ioannou","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.tcm.2007.02.006_bib28","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1073\/pnas.051634498","article-title":"Adeno-associated vira vector-mediated gene transfer results in long-term enzymatic and functional correction in multiple organs ofFabry mice","volume":"98","author":"Jung","year":"2001","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.tcm.2007.02.006_bib29","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF01804397","article-title":"Different phenotypic expression of Fabry disease in female monozygotic twins","volume":"14","author":"Levade","year":"1991","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.tcm.2007.02.006_bib30","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/ana.410400105","article-title":"Cerebrovascular complications of Fabry's disease","volume":"40","author":"Mitsias","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.tcm.2007.02.006_bib31","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1161\/hc3801.096352","article-title":"Regional cerebral hyperperfusion and nitric oxide pathway dysregulation in Fabry disease","volume":"104","author":"Moore","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2007.02.006_bib32","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1161\/01.ATV.15.10.1607","article-title":"Glycosphingolipid accumulation in the aortic wall is another feature of human atherosclerosis","volume":"15","author":"Mukhin","year":"1995","journal-title":"Atheroscler Thromb Vasc Biol"},{"key":"10.1016\/j.tcm.2007.02.006_bib48","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1161\/01.CIR.0000087480.94275.97","article-title":"From vulnerable plaque to vulnerable patient: A call for new definitions and risk assessmentstrategies: Part 1","volume":"108","author":"Naghavi","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2007.02.006_bib33","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2340\/00015555613741","article-title":"Angiokeratoma corporis diffusum (Fabry disease): ultrastructural studies of the skin","volume":"61","author":"Nakamura","year":"1981","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.tcm.2007.02.006_bib34","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1056\/NEJM199508033330504","article-title":"An atypical variant of Fabry's disease in men with left ventricular hypertrophy","volume":"333","author":"Nakao","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2007.02.006_bib35","doi-asserted-by":"crossref","first-page":"6423","DOI":"10.1073\/pnas.96.11.6423","article-title":"Aging accentuates and bone marrow transplantation ameliorates metabolic defects in Fabry disease mice","volume":"96","author":"Ohshima","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.tcm.2007.02.006_bib36","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.0954-6820.1947.tb06596.x","article-title":"Angiokeratoma corporis diffusum (universale) Fabry, as a sign of an unknown internal diseases; two autopsy reports","volume":"128","author":"Pompen","year":"1947","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.tcm.2007.02.006_bib37","first-page":"295","article-title":"Non invasive evaluation of endothelial function in patients with Anderson-Fabry disease","volume":"24","author":"Puccio","year":"2005","journal-title":"Int Angiol"},{"key":"10.1016\/j.tcm.2007.02.006_bib38","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1016\/S0140-6736(05)67635-0","article-title":"Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study","volume":"366","author":"Rolfs","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.tcm.2007.02.006_bib39","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1001\/jama.285.21.2743","article-title":"Enzyme replacement therapy in Fabry disease (a randomized controlled trial)","volume":"285","author":"Schiffmann","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.tcm.2007.02.006_bib40","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00428-005-0089-x","article-title":"Pathological findings in a patient with Fabry disease who died after 2.5 years of enzyme replacement","volume":"448","author":"Schiffmann","year":"2006","journal-title":"Virchows Arch"},{"key":"10.1016\/j.tcm.2007.02.006_bib41","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1161\/01.STR.0000206442.86238.39","article-title":"alpha-Galactosidase A deficiency leads to increased tissue fibrin deposition and thrombosis in mice homozygous for the factor V Leiden mutation","volume":"37","author":"Shen","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.tcm.2007.02.006_bib42","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0272-6386(83)80047-X","article-title":"Early renal failure in Fabry's disease","volume":"2","author":"Sheth","year":"1983","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.tcm.2007.02.006_bib43","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1042\/bj1040340","article-title":"Lipid composition of human serum lipoproteins","volume":"104","author":"Skipski","year":"1967","journal-title":"Biochem J"},{"key":"10.1016\/j.tcm.2007.02.006_bib44","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1056\/NEJM199402243300801","article-title":"Resistance to activated protein C as a basis for venous thrombosis","volume":"330","author":"Svensson","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2007.02.006_bib45","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1016\/S0021-9258(18)51888-3","article-title":"Fabry's disease: classification as a sphyngolipidosis and partial characterisation of a novel glycolipid","volume":"238","author":"Sweeley","year":"1963","journal-title":"J Biol Chem"},{"key":"10.1016\/j.tcm.2007.02.006_bib46","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2169\/internalmedicine.36.327","article-title":"High incidence of thrombosis in Fabry's disease","volume":"36","author":"Utsumi","year":"1997","journal-title":"Intern Med"},{"key":"10.1016\/j.tcm.2007.02.006_bib47","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1159\/000169023","article-title":"Novel frameshift mutation in a heterozygous woman with Fabry disease and end-stage renal failure","volume":"16","author":"Van Loo","year":"1996","journal-title":"Am J Nephrol"}],"container-title":["Trends in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173807000503?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173807000503?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T18:29:18Z","timestamp":1683829758000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1050173807000503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S1050173807000503"],"URL":"https:\/\/doi.org\/10.1016\/j.tcm.2007.02.006","relation":{},"ISSN":["1050-1738"],"issn-type":[{"value":"1050-1738","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}